PolyMedix Defensin-Mimetic Antimicrobial Compounds Show Activity Against Oral Candida Fungus and Malaria – MarketWatch

At the same scientific meeting, Dr. Doron Greenbaum, Assistant Professor of Pharmacology at the University of Pennsylvania, presented in vitro and in vivo data showing that PolyMedixs antimicrobial compounds show promising activity in experimental models of malaria. The data presented showed that PolyMedixs antimicrobial compounds potently killed the parasite that causes malaria, Plasmodium falciparum, in infected human red blood cells, without damaging uninfected red blood cells. The compounds appear to rapidly target the membrane of the digestive vacuole of the parasite via a unique mechanism which is distinct from other anti-malarial agents. Encouraging in vivo activity was also reported with a potential lead compound on malaria parasite clearance and animal survival in a mouse malaria model. This work was supported under a Fast Track SBIR grant received from the National Institute of Health NIH.

via PolyMedix Defensin-Mimetic Antimicrobial Compounds Show Activity Against Oral Candida Fungus and Malaria – MarketWatch.

Advertisements


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s